Cargando…
Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice
Sodium phenylacetate (NaPa) and carboxymethyl benzylamide dextran derivative (CMDB(LS4)) are able to inhibit growth of breast tumour cells. In this study, we explored whether the combination of NaPa and CMDB(LS4) may enhance their respective inhibitory effects on the MCF-7ras cell growth in vitro an...
Autores principales: | Benedetto, M Di, Kourbali, Y, Starzec, A, Vassy, R, Jozefonvicz, J, Perret, G, Crepin, M, Kraemer, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375080/ https://www.ncbi.nlm.nih.gov/pubmed/11556846 http://dx.doi.org/10.1054/bjoc.2001.1993 |
Ejemplares similares
-
Carboxymethyl benzylamide dextran inhibits angiogenesis and growth of VEGF-overexpressing human epidermoid carcinoma xenograft in nude mice
por: Hamma-Kourbali, Y, et al.
Publicado: (2003) -
Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative
por: Di Benedetto, M, et al.
Publicado: (2003) -
A novel sodium phenylacetate-dextran derivative ester inhibits the growth and angiogenesis of MCF-7ras breast cancer xenografts
por: Benedetto, M Di, et al.
Publicado: (2001) -
Decrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive molecules
por: Vasse, M, et al.
Publicado: (2001) -
A novel phenylacetate-dextran derivative (NaPaC) inhibits breast cancer cell proliferation and modifies their interactions with endothelial cells
por: Malherbe, S, et al.
Publicado: (2001)